EX-10.1



 Exhibit 10.1 

Northern Oil and Gas, Inc. 

(Minnesota corporation) 

$200,000,000 8.000% Senior Notes due 2020 

PURCHASE AGREEMENT 

Dated: May 13, 2015 







 May 13, 2015 

RBC Capital Markets, LLC 
 As Representative
of the several Initial Purchasers 
 listed in Schedule 1 hereto 

Three World Financial Center 
 200 Vesey Street, 10th Floor 

New York, NY 10281 
 Ladies and Gentlemen: 

Northern Oil and Gas, Inc., a Minnesota corporation (the “Company”), proposes to issue and sell to the several initial
purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as Representative (the “Representative”), $200,000,000 aggregate principal amount of its 8.000% Senior Notes due 2020
(the “Securities”). The Securities will be issued pursuant to an Indenture to be dated as of May 18, 2015 (the “Indenture”) between the Company and Wilmington Trust, National Association, as trustee (the
“Trustee”). 
 The Securities will be sold to the Initial Purchasers without being registered under the Securities Act of
1933, as amended (the “Securities Act”), in reliance upon an exemption therefrom. In connection with the sale of the Securities, the Company has prepared a preliminary offering memorandum dated May 13, 2015 (the
“Preliminary Offering Memorandum”) and has prepared a pricing supplement substantially in the form attached hereto as Exhibit B (the “Pricing Supplement”) dated May 13, 2015, setting forth or including a
description of the terms of the Securities, each for use by the Initial Purchasers in connection with the offering of the Securities. The Preliminary Offering Memorandum and the information included in Exhibit A hereto, if any, are herein referred
to as the “Time of Sale Memorandum.” Promptly after the Time of Sale (as defined below), the Company will prepare and deliver to each Initial Purchaser an offering memorandum (the “Offering Memorandum”), which will
consist of the Preliminary Offering Memorandum with such changes therein as are required to reflect the information contained in the Pricing Supplement, and from and after the time such Offering Memorandum is delivered to each Initial Purchaser, all
references herein to the Offering Memorandum shall be deemed to be a reference to both the Preliminary Offering Memorandum and the Offering Memorandum. The time when sales of the Securities were first made means 2:54 p.m., New York City Time, on the
date of this Agreement (the “Time of Sale”). 
 Holders of the Securities will be entitled to the benefits of a
registration rights agreement, to be dated as of May 18, 2015 (the “Registration Rights Agreement”), among the Company and the Initial Purchasers, pursuant to which the Company may be required to file with the Securities and
Exchange Commission (the “Commission”), under the circumstances set forth therein, (i) a registration statement under the Securities Act relating to another issuance of debt securities of the Company with terms substantially
identical to the Securities and of the same series under the Indenture as the Securities (the “Exchange Securities”) to be offered in exchange for the Securities (the “Exchange Offer”) and (ii) to the extent
required by the Registration Rights Agreement, a shelf registration statement pursuant to Rule 415 of the Securities Act 

  
 2 








 
relating to the resale by certain holders of the Securities, and in each case, to use its commercially reasonable efforts to cause such registration statements to be declared effective. 

The Company hereby confirms its agreement with the several Initial Purchasers concerning the purchase and resale of the Securities, as
follows: 
 1. Representations and Warranties of the Company. The Company represents and warrants to each Initial Purchaser that:

 (a) No Registration Required. Subject to compliance by the Initial Purchasers with the representations and warranties set forth in
Section 2(b) hereof, it is not necessary in connection with the offer, sale and delivery of the Securities to the Initial Purchasers and to each subsequent purchaser in the manner contemplated by this Agreement and the Time of Sale Memorandum
and the Offering Memorandum to register the Securities under the Securities Act or, until such time as the Exchange Securities are issued pursuant to an effective registration statement, to qualify the Indenture under the Trust Indenture Act of
1939, as amended (the “Trust Indenture Act”). 
 (b) Integration. Neither the Company nor any affiliate (as defined
in Rule 501(b) of Regulation D under the Securities Act, an “Affiliate”) of the Company has directly, or through any agent, (i) sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as
defined in the Securities Act) which is or will be integrated with the sale of the Securities in a manner that would require the registration under the Securities Act of the Securities or (ii) offered, solicited offers to buy or sold the
Securities by any form of general solicitation or general advertising (as those terms are used in Regulation D under the Securities Act) or in any manner involving a public offering within the meaning of Section 4(2) of the Securities Act. 

(c) No General Solicitation or Directed Selling Efforts. Neither the Company, its Affiliates nor any person acting on its or their
behalf has engaged or will engage in any directed selling efforts (within the meaning of Regulation S) with respect to the Securities; and the Company and its Affiliates and any person acting on its or their behalf have complied and will comply with
the offering restrictions requirement of Regulation S, except no representation, warranty or agreement is made by the Company in this paragraph with respect to the Initial Purchasers. 

(d) Preliminary Offering Memorandum, Time of Sale Memorandum and Offering Memorandum. The Preliminary Offering Memorandum, as of its
date, did not, the Time of Sale Memorandum, at the Time of Sale, did not, and at the Closing Date (as defined in Section 3) will not, and the Offering Memorandum, as of its date and as of the Closing Date, will not, contain any untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Company makes no representation or warranty with
respect to any statements or omissions made in reliance upon and in conformity with information relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use in the
Preliminary Offering Memorandum, the Time of Sale Memorandum or the Offering Memorandum. 

  
 3 








 (e) Additional Written Communications. Other than the Preliminary Offering Memorandum, the
Pricing Supplement and the Offering Memorandum, the Company (including its agents and representatives, other than the Initial Purchasers in their capacity as such) has not made, used, prepared, authorized, approved or referred to and will not
prepare, make, use, authorize, approve or refer to any written communication that constitutes an offer to sell or solicitation of an offer to buy the Securities other than the documents listed on Exhibit A hereto, including the Pricing Supplement,
and other written communications used in accordance with Section 4(b). 
 (f) Organization and Good Standing of the Company. The
Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction of its incorporation and has corporate power and authority to own, lease and operate its properties and to conduct its
business as described in the Time of Sale Memorandum and the Offering Memorandum and to enter into and perform its obligations under this Agreement, the Registration Rights Agreement, the Securities, the Exchange Securities and the Indenture. The
Company is duly qualified to transact business and is in good standing as a foreign corporation or other legal entity in each other jurisdiction in which its ownership or leasing of property or the conduct of its business requires such
qualification, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the general affairs, management, business, properties,
condition (financial or otherwise), results of operations or prospects of the Company taken as a whole or on the performance by the Company of its obligations under the Securities (a “Material Adverse Effect”). 

(g) Eligibility for Resale under Rule 144A. The Securities are eligible for resale pursuant to Rule 144A and will not be, at
the Closing Date, of the same class as securities listed on a national securities exchange registered under Section 6 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or quoted in a U.S. automated
interdealer quotation system. 
 (h) Subsidiaries. The Company does not have any subsidiaries and does not own any beneficial
interest, directly or indirectly, in any corporation, partnership, joint venture or other business entity. 
 (i) Purchase Agreement.
This Agreement has been duly and validly authorized, executed and delivered by the Company. 
 (j) Registration Rights Agreement. The
Registration Rights Agreement has been duly authorized by the Company and on the Closing Date will be duly executed and delivered by the Company and, when duly executed and delivered in accordance with its terms by each of the parties thereto, will
constitute a valid and legally binding agreement of the Company enforceable against the Company in accordance with its terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar
laws relating to or affecting the rights and remedies 

  
 4 








 
of creditors generally or by general equitable principles (regardless of whether enforceability is considered a proceeding in equity or at law). 

(k) Indenture. The Indenture has been duly authorized by the Company and on the Closing Date will be duly executed and delivered by the
Company and, when duly executed and delivered in accordance with its terms by each of the parties thereto, will constitute a valid and legally binding agreement of the Company enforceable against the Company in accordance with its terms, except as
the enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors generally or by general equitable principles (regardless of whether
enforceability is considered in a proceeding in equity or at law). The Indenture meets the requirements for qualification under the Trust Indenture Act. 

(l) The Securities and the Exchange Securities. The Securities have been duly authorized by the Company and, when duly executed,
authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be duly and validly issued and outstanding and will constitute valid and legally binding obligations of the Company enforceable against the
Company in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors generally or by
general equitable principles (regardless of whether enforceability is considered in a proceeding in equity or at law), and will be entitled to the benefits of the Indenture. The Exchange Securities have been duly and validly authorized for issuance
by the Company, and when issued and authenticated in accordance with the terms of the Indenture and the Exchange Offer, will constitute valid and binding obligations of the Company enforceable against the Company in accordance with their terms,
except as the enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors generally or by general equitable principles (regardless of
whether enforceability is considered in a proceeding in equity or at law) and will be entitled to the benefits of the Indenture. 
 (m)
Description of this Agreement, the Registration Rights Agreement, the Securities, the Exchange Securities and the Indenture. This Agreement, the Registration Rights Agreement, the Securities, the Exchange Securities and the Indenture will
conform in all material respects to the respective statements relating thereto contained in the Time of Sale Memorandum and the Offering Memorandum. 

(n) No Violation or Default. The Company is not (i) in violation of its charter or by-laws; (ii) in breach of or default
under (nor has any event occurred that, with notice or passage of time or both, would constitute a default under) or in violation of any of the terms or provisions of any indenture, mortgage, deed of trust, loan agreement or other agreement or
instrument to which it is a party or to which it or its properties or assets is subject; or (iii) in violation of any law, statute, rule, regulation, judgment order or decree of any court or governmental agency or body, domestic or foreign,
having jurisdiction over the Company or any of its properties or assets, except, in the case of clauses (ii) and (iii) above, for any such default or violation that has been waived or would not, individually or in the aggregate, have a
Material Adverse Effect. 

  
 5 








 (o) Capitalization. The information set forth under the caption “Capitalization”
in the Time of Sale Memorandum and the Offering Memorandum is fairly presented on a basis consistent with the Company’s financial statements (other than for subsequent issuances of capital stock, if any, pursuant to employee benefit plans
described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2014, including information incorporated by reference therein (the “2014 Annual Report”), or upon exercise of outstanding
options described in the 2014 Annual Report). There are no authorized or outstanding shares of capital stock, options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities convertible into or
exchangeable or exercisable for, any capital stock of the Company other than those described in the 2014 Annual Report. The description of the Company’s stock option, stock bonus and other stock plans or arrangements, and the options or other
rights granted thereunder, as described in the 2014 Annual Report, accurately and fairly present the information that would be required to be included in a registration statement on Form S-1 with respect to such plans, arrangements, options and
rights. 
 (p) No Conflict. The execution and delivery by the Company of this Agreement, the Registration Rights Agreement, the
Indenture, the Securities and the Exchange Securities by the Company and the performance by the Company of its obligations thereunder will not (i) conflict with or result in a breach or violation of, or constitute a default under (nor
constitute any event which with or without notice, lapse of time or both would result in any breach or violation of or constitute a default under), give rise to any right of termination or other right or the cancellation or acceleration of any right
or obligation or loss of a benefit under, or give rise to the creation or imposition of any lien, encumbrance, security interest, claim or charge upon any property or assets of the Company pursuant to any indenture, mortgage, deed of trust, loan
agreement or other contract, agreement or instrument to which the Company is a party or by which the Company is bound or to which any of its property or assets is subject, (ii) result in any violation of the provisions of the charter or by-laws
of the Company, or (iii) result in any violation of any law, statute, rule, regulation, judgment, order or decree of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Company or any of its properties or
assets, except, in the case of clauses (i) and (iii) above, for any such conflict, breach, violation or default that would not, individually or in the aggregate, have a Material Adverse Effect. 

(q) No Consents Required. No consent, approval, authorization, order, registration or qualification of or with any court or arbitrator
or governmental or regulatory authority is required for the execution and delivery by the Company of this Agreement, the Registration Rights Agreement, the Indenture, the Securities and the Exchange Securities and the performance by the Company of
its obligations hereunder and thereunder, except for such consents, approvals, authorizations, orders and registrations or qualifications as may be required under applicable state securities laws or the securities laws of any foreign jurisdictions
in connection with the purchase and resale of the Securities by the Initial Purchasers and except such as may be required under applicable state securities laws or the securities laws of any foreign jurisdictions with respect to the Company’s
obligations under the Registration Rights Agreement. 

  
 6 








 (r) Registration Rights. There are no contracts, agreements or understandings between the
Company and any person granting such person the right (other than rights which have been waived in writing in connection with the transactions contemplated by this Agreement or otherwise satisfied) to require the Company to register any securities
with the Commission. 
 (s) Accuracy of Disclosure. The statements in the Time of Sale Memorandum and the Offering Memorandum under
the captions “Risk Factors,” “Certain Relationships and Related Transactions,” and “Description of Other Indebtedness,” and the statements in our 2014 Annual Report under the captions “Risk Factors—Risks
Related To Our Business—Environmental risks may adversely affect our business,” “Risk Factors—Risks Related To Our Business—Federal and state legislative and regulatory initiatives relating to hydraulic fracturing could
result in increased costs and additional operating restrictions or delays,” “Management,” “Certain Relationships and Related Transactions,” and “Business—Governmental Regulation and Environmental Matters,”
which are incorporated by reference into the Time of Sale Memorandum and the Offering Memorandum, insofar as such statements summarize legal matters, agreements, documents or proceedings discussed therein, are accurate and fair summaries of such
legal matters, agreements, documents and proceedings. 
 (t) Independent Accountants. Each of Mantyla, McReynolds LLC
(“Mantyla”) and Deloitte & Touche LLP (“Deloitte”), who have audited certain financial statements of the Company included in the Time of Sale Memorandum and the Offering Memorandum, and Grant Thornton LLP
(collectively with Mantyla and Deloitte, the “Independent Accountants”), is (i) an independent public accounting firm within the meaning of the Securities Act, (ii) a registered public accounting firm (as defined in
Section 2(a)(12) of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”)), and (iii) not in violation of the auditor independence requirements of the Sarbanes-Oxley Act. Except as disclosed in the Time of Sale
Memorandum and the Offering Memorandum and as pre-approved in accordance with the requirements set forth in Section 10A of the Exchange Act, none of Mantyla, McReynolds LLC, Deloitte & Touche LLP nor Grant Thornton LLP has been engaged
by the Company to perform any “prohibited activities” (as defined in Section 10A of the Exchange Act). 
 (u) Financial
Statements. The consolidated financial statements of the Company, together with the related schedules and notes thereto, set forth in each of the Time of Sale Memorandum and the Offering Memorandum comply in all material respects with the
applicable requirements of the Securities Act and present fairly in all material respects (i) the financial condition of the Company as of the dates indicated and (ii) the consolidated results of operations, stockholders’ equity and
changes in cash flows of the Company for the periods therein specified; and such financial statements and related schedules and notes thereto have been prepared in conformity with United States generally accepted accounting principles, consistently
applied throughout the periods involved (except as otherwise stated therein and subject, in the case of unaudited financial statements, to the absence of footnotes and normal year-end adjustments). There are no other financial statements (historical
or pro forma) that would be required to be included in a registration statement on Form S-1 that are not included in the Time of Sale Memorandum and the Offering Memorandum; and the Company does not have any material liabilities or obligations,
direct or contingent (including any off-balance sheet obligations), not disclosed in the Time of Sale Memorandum and the Offering Memorandum; and all disclosures contained in the Time of Sale Memorandum and the Offering Memorandum


  
 7 








 
regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission) comply with Regulation G of the Exchange Act and Item 10(e) of
Regulation S-K under the Securities Act, to the extent applicable, and present fairly the information shown therein and the Company’s basis for using such measures. 

(v) Absence of Material Changes. Subsequent to the respective dates as of which information is contained in the Time of Sale Memorandum
and the Offering Memorandum and except as may be otherwise stated in the Time of Sale Memorandum and the Offering Memorandum, there has not been (i) any Material Adverse Effect, (ii) any transaction which is material to the Company and out
of the ordinary course of business, (iii) any obligation, direct or contingent (including any off-balance sheet obligations), incurred by the Company, which is material to the Company, (iv) any dividend or distribution of any kind
declared, paid or made on the capital stock of the Company, (v) any change in the capital stock (other than a change in the number of outstanding shares of common stock of the Company due to the issuance of shares upon the exercise of
outstanding options or warrants or the conversion of convertible indebtedness and the issuance of shares of restricted stock), (vi) any material change in the short-term debt or long-term debt of the Company (other than upon conversion of
convertible indebtedness) or (vii) any issuance of options, warrants, convertible securities or other rights to purchase the capital stock (other than grants of stock options under the Company’s stock option plans existing on the date
hereof) of the Company. 
 (w) Legal Proceedings. There are no legal or governmental actions, suits, claims or proceedings pending
or, to the Company’s knowledge, threatened or contemplated to which the Company is or would be a party or of which any of its properties is or would be subject at law or in equity, before or by any federal, state, local or foreign governmental
or regulatory commission, board, body, authority or agency, or before or by any self-regulatory organization or other non-governmental regulatory authority that would be required to be included in a registration statement on Form S-1 that are not so
described in the Time of Sale Memorandum and the Offering Memorandum, or which, singularly or in the aggregate, if resolved adversely to the Company, would reasonably be expected to result in a Material Adverse Effect or prevent or materially and
adversely affect the ability of the Company to consummate the transactions contemplated hereby. To the Company’s knowledge, no such proceedings are threatened or contemplated by governmental authorities or threatened by other third parties.

 (x) Permits. The Company has made all filings, applications and submissions required by, and owns or possesses all approvals,
licenses, certificates, certifications, clearances, consents, exemptions, marks, notifications, orders, permits and other authorizations issued by, the appropriate federal, state or foreign regulatory authorities, necessary to conduct its business
as described in the Time of Sale Memorandum and the Offering Memorandum (collectively, “Permits”), and is in compliance in all material respects with the terms and conditions of all such Permits. All such Permits are valid and in
full force and effect. The Company has not received any notice of any proceedings relating to revocation or modification of, any such Permit, which, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding,
would have a Material Adverse Effect. 

  
 8 








 (y) Not an Investment Company. The Company is not and, after giving effect to the offering
and sale of the Securities and the application of the proceeds therefrom as described in the Time of Sale Memorandum and the Offering Memorandum, will not be (i) required to register as an “investment company” as defined in the
Investment Company Act of 1940, as amended (the “Investment Company Act”), and the rules and regulations of the Commission thereunder or (ii) a “business development company” (as defined in Section 2(a)(48) of
the Investment Company Act). 
 (z) No Price Stabilization. Neither the Company nor any of the Company’s officers or directors,
has taken or will take, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in, or which has constituted or which might reasonably be expected to constitute, the stabilization or manipulation of the
price of any security of the Company to facilitate the sale or resale of the Securities. 
 (aa) Good Title to Property. The Company
has good and valid title to all property (whether real or personal) described in the Time of Sale Memorandum and the Offering Memorandum as being owned by it, in each case free and clear of all liens, claims, security interests, other encumbrances
or defects (collectively, “Liens”), except such as are described in the Time of Sale Memorandum and the Offering Memorandum and those that would not, individually or in the aggregate materially affect the value of such property and
do not materially interfere with the use made and proposed to be made of such property by the Company. All of the property described in the Time of Sale Memorandum and the Offering Memorandum as being held under lease by the Company is held thereby
under valid, subsisting and enforceable leases, without any liens, restrictions, encumbrances or claims, except such as are described in the Time of Sale Memorandum and the Offering Memorandum and those that, individually or in the aggregate, are
not material and do not materially interfere with the use made and proposed to be made of such property by the Company. 
 (bb)
Intellectual Property Rights. The Company owns or possesses the right to use all patents, trademarks, trademark registrations, service marks, service mark registrations, trade names, copyrights, licenses, inventions, software, databases,
know-how, Internet domain names, trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures, and other intellectual property (collectively, “Intellectual Property”)
necessary to carry on its businesses as currently conducted, and as proposed to be conducted as described in the Time of Sale Memorandum and the Offering Memorandum, and the Company is not aware of any claim to the contrary or any challenge by any
other person to the rights of the Company with respect to the foregoing except for those that could not have a Material Adverse Effect. The Intellectual Property licenses described in the Time of Sale Memorandum and the Offering Memorandum are, to
the knowledge of the Company, valid, binding upon, and enforceable by or against the parties thereto in accordance with their terms. The Company has complied in all material respects with, and is not in breach nor has received any asserted or
threatened claim of breach of, any Intellectual Property license, and the Company has no knowledge of any breach or anticipated breach by any other person of any Intellectual Property license. The Company’s business as now conducted and as
proposed to be conducted, to the knowledge of the Company, does not and will not infringe or conflict with any patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses or other Intellectual Property or franchise right of
any person. The Company has not received notice of any claim 

  
 9 








 
against the Company alleging the infringement by the Company of any patent, trademark, service mark, trade name, copyright, trade secret, license in or other intellectual property right or
franchise right of any person. The Company has taken all reasonable steps to protect, maintain and safeguard its rights in all Intellectual Property, including the execution of appropriate nondisclosure and confidentiality agreements. The
consummation of the transactions contemplated by this Agreement will not result in the loss or impairment of or payment of any additional amounts with respect to, nor require the consent of any other person in respect of, the Company’s right to
own, use, or hold for use any of the Intellectual Property as owned, used or held for use in the conduct of the businesses as currently conducted. To the Company’s knowledge, no employee of the Company is the subject of any claim or proceeding
involving a violation of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former
employer where the basis of such violation relates to such employee’s employment with the Company or actions undertaken by the employee while employed with the Company. 

(cc) No Labor Disputes. No labor problem or dispute with the employees of the Company exists, or, to the Company’s knowledge, is
threatened or imminent, which would reasonably be expected to result in a Material Adverse Effect. The Company is not aware that any key employee or significant group of employees of the Company plans to terminate employment with the Company. The
Company has not engaged in any unfair labor practice and except for matters which would not, individually or in the aggregate, result in a Material Adverse Effect, (i) there is (A) no unfair labor practice complaint pending or, to the
Company’s knowledge, threatened against the Company before the National Labor Relations Board, and no grievance or arbitration proceeding arising out of or under collective bargaining agreements is pending or to the Company’s knowledge,
threatened, (B) no strike, labor dispute, slowdown or stoppage pending or, to the Company’s knowledge, threatened against the Company and (C) no union representation dispute currently existing concerning the employees of the Company
and (ii) to the Company’s knowledge, (A) no union organizing activities are currently taking place concerning the employees of the Company and (B) there has been no violation of any federal, state, local or foreign law relating
to discrimination in the hiring, promotion or pay of employees, any applicable wage or hour laws or any provision of the Employee Retirement Income Security Act of 1974 (“ERISA”) or the rules and regulations promulgated thereunder
concerning the employees of the Company. 
 (dd) Taxes. The Company (i) has timely filed all necessary federal, state, local and
foreign income, franchise and other material tax returns (or timely filed applicable extensions therefor) that have been required to be filed and (ii) has paid all taxes, any assessments, fines, interest or penalties with respect thereto, other
than any of which the Company is contesting in good faith by appropriate proceedings diligently conducted and for which adequate reserves have been provided and reflected in the Company’s financial statements included in the Time of Sale
Memorandum and the Offering Memorandum. The Company does not have any tax deficiency that has been or is reasonably likely to be asserted or threatened against it that would, individually or in the aggregate, result in a Material Adverse Effect. The
Company has not engaged in any transaction which is a reportable transaction, corporate tax shelter or which could be characterized as such by the Internal Revenue Service or any other taxing authority. 

  
 10 








 (ee) ERISA. The Company is in compliance in all material respects with all presently
applicable provisions of ERISA; no “reportable event” (as defined in ERISA) has occurred with respect to any “pension plan” (as defined in ERISA) for which the Company would have any liability; the Company has not incurred and
does not expect to incur liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any “pension plan” or (ii) Sections 412 or 4971 of the Internal Revenue Code of 1986, as amended, including the
regulations and published interpretations thereunder (the “Code”); and each “pension plan” for which the Company would have any liability that is intended to be qualified under Section 401(a) of the Code is so
qualified in all material respects and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification. 

(ff) Compliance with Environmental Laws. The Company (i) is in compliance with any and all applicable foreign, federal, state and
local laws, orders, rules, regulations, directives, decrees and judgments relating to the use, treatment, storage and disposal of hazardous or toxic substances or waste and protection of human health and safety or the environment which are
applicable to its business (“Environmental Laws”); (ii) has received and is in compliance with all permits, licenses or other approvals required of it under applicable Environmental Laws to conduct its business; and
(iii) is in compliance with all terms and conditions of any such permit, license or approval, except where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with
the terms and conditions of such permits, licenses or approvals would not, individually or in the aggregate, result in a Material Adverse Effect. There are no costs or liabilities associated with Environmental Laws (including, without limitation,
any capital or operating expenditures required for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third
parties) which would, individually or in the aggregate, result in a Material Adverse Effect. 
 (gg) Insurance. The Company maintains
or is covered by insurance provided by recognized, financially sound and reputable institutions with insurance policies in such amounts and covering such risks as is adequate for the conduct of its business and the value of its properties and as is
customary for companies engaged in similar businesses in similar industries. All such insurance is fully in force on the date hereof and will be fully in force as of the Closing Date. The Company has no reason to believe that it will not be able to
renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect. The Company has not
been denied any material insurance policy or coverage for which it has applied. The Company does not insure risk of loss through any captive insurance, risk retention group, reciprocal group or by means of any fund or pool of assets specifically set
aside for contingent liabilities other than as described in the Time of Sale Memorandum and the Offering Memorandum. 
 (hh) Accounting
Controls. The Company maintains a system of accounting controls that is in compliance with the Sarbanes-Oxley Act and is sufficient to provide reasonable assurances that: (i) transactions are executed in accordance with management’s
general or specific authorization; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles as applied in


  
 11 








 
the United States and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and
(iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences. 

(ii) Disclosure Controls. The Company has established, maintains and evaluates “disclosure controls and procedures” (as such
term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act), which (i) are designed to ensure that material information relating to the Company is made known to the Company’s principal executive officer and its principal
financial officer by others within the Company, particularly during the periods in which the periodic reports required under the Exchange Act are being prepared, (ii) have been evaluated for effectiveness as of the end of the last fiscal period
covered by the Offering Memorandum; and (iii) are effective to perform the functions for which they were established. There are no significant deficiencies or material weaknesses in the design or operation of internal controls which could
adversely affect the Company’s ability to record, process, summarize, or report financial data to management and the Board of Directors of the Company. The Company is not aware of any fraud, whether or not material, that involves management or
other employees who have a role in the Company’s internal controls; and since the date of the most recent evaluation of such disclosure controls and procedures, there have been no significant changes in internal controls or in other factors
that could significantly affect internal controls, including any corrective actions with regard to significant deficiencies and material weaknesses. Except as set forth in the Time of Sale Memorandum and the Offering Memorandum, the Audit Committee
of the Board of Directors of the Company (the “Audit Committee”) is not reviewing or investigating, and neither the Company’s independent auditors nor its internal auditors have recommended that the Audit Committee review or
investigate, (i) adding to, deleting, changing the application of or changing the Company’s disclosure with respect to, any of the Company’s material accounting policies, (ii) any manner which could result in a restatement of the
Company’s financial statements for any annual or interim period during the current or prior three fiscal years, or (iii) a significant deficiency, material weakness, change in internal control over financial reporting or fraud involving
management or other employees who have a significant role in the internal control over financial reporting. 
 (jj) Contracts;
Off-Balance Sheet Interests. There is no document, contract, permit or instrument, or off-balance sheet transaction (including without limitation, any “variable interests” in “variable interest entities,” as such terms are
defined in Financial Accounting Standards Board Interpretation No. 46) of a character required by the Securities Act or the rules and regulations of the Commission thereunder to be described in the Time of Sale Memorandum and the Offering
Memorandum which is not described or filed as required. Each description of a document, contract, permit or instrument in the Time of Sale Memorandum and the Offering Memorandum accurately reflects in all material respects the terms of the
underlying document, contract, permit or instrument. The documents, contracts, permits and instruments described in the immediately preceding sentence to which the Company is a party have been duly authorized, executed and delivered by the Company,
constitute valid and binding agreements of the Company, are enforceable against and by the Company in accordance with the terms thereof and are in full force and effect on the date hereof. Neither the Company, or to the Company’s knowledge, any
other party is in default in the observance or performance of any term or obligation to be performed by it under any such agreement, and no event has occurred which 

  
 12 








 
with notice or lapse of time or both would constitute such a default, in any case which default or event, individually or in the aggregate, would have a Material Adverse Effect. 

(kk) No Undisclosed Relationships. No relationship, direct or indirect, exists between or among the Company on the one hand and the
directors, officers, stockholders, customers or suppliers of the Company or any of their affiliates on the other hand, which would be required to be disclosed in a registration statement on Form S-1 pursuant to Item 404 of Regulation S-K under
the Securities Act that are not so described in the Time of Sale Memorandum and the Offering Memorandum. 
 (ll) Brokers Fees. There
are no contracts, agreements or understandings between the Company and any person (other than this Agreement) that would give rise to a claim against the Company or the Initial Purchasers for a brokerage commission, finder’s fee or other like
payment in connection with the offering and sale of the Securities. 
 (mm) Forward-Looking Statements. No forward-looking statements
(within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained in the Time of Sale Memorandum or the Offering Memorandum have been made or reaffirmed without a reasonable basis therefor or have been
disclosed other than in good faith. 
 (nn) Sarbanes-Oxley Act. The Company, and to its knowledge, each of the Company’s
directors or officers, in their capacities as such, is in compliance in all material respects with all applicable effective provisions of the Sarbanes-Oxley Act and any related rules and regulations promulgated by the Commission. Each of the
principal executive officer and the principal financial officer of the Company (and each former principal executive officer of the Company and each former principal financial officer of the Company as applicable) has made all certifications required
by Sections 302 and 906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements and other documents required to be filed by him or her with the Commission. For purposes of the preceding sentence, “principal executive
officer” and “principal financial officer” shall have the meanings given to such terms in the Sarbanes-Oxley Act. 
 (oo)
Affiliate Transactions. There are no transactions, arrangements or other relationships between and/or among the Company, any of its affiliates (as such term is defined in Rule 405) and any unconsolidated entity, including, but not limited to,
any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially affect the Company’s liquidity or the availability of or requirements for its capital resources that would be required to be
included in a registration statement on Form S-1 which have not been described in the Time of Sale Memorandum and the Offering Memorandum. The Company does not, directly or indirectly, have any
outstanding personal loans or other credit extended to or for any of its directors or executive officers. 
 (pp) Statistical or
Market-Related Data. Any statistical, industry-related or market-related data included in the Time of Sale Memorandum and the Offering Memorandum are based on or derived from sources that the Company reasonably and in good faith believes to be
reliable and accurate, and such data agree with the sources from which they are derived. 

  
 13 








 (qq) No Unlawful Contributions or Other Payments. Neither the Company nor, to the
Company’s knowledge, any of its affiliates, any director, officer, or employee nor any agent or representative of the Company or of any of its affiliates, has (i) taken or will take any action in furtherance of an offer, payment, promise
to pay, or authorization or approval of the payment or giving of money, property, gifts or anything else of value, directly or indirectly, to any foreign or domestic “government official” (including any officer or employee of a government
or government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office) to
influence official action or secure an improper advantage, (ii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977 (together with the rules and regulations promulgated thereunder, the
“FCPA”), or (iii) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment; and the Company and its affiliates have conducted their businesses in compliance with the FCPA and other applicable
anti-corruption laws and have instituted and maintained and will continue to maintain policies and procedures designed to promote and achieve compliance with such laws and with the representation and warranty contained herein. 

(rr) No Conflict with Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance
in all material respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA PATRIOT Act, the money laundering statutes of all applicable
jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money Laundering Laws”) and no
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. 

(ss) Compliance with OFAC. Neither the Company nor, to the knowledge of the Company, any director, officer, agent, employee or
affiliate of the Company is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly or indirectly use the proceeds of
the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any affiliate, joint venture partner or other person or entity, which, to the Company’s knowledge, will use such proceeds for the purpose
of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC. 
 (tt) Margin Securities.
None of the proceeds of the sale of the Securities will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness which was originally incurred to
purchase or carry any margin security or for any other purpose which might cause any of the Securities to be considered a “purpose credit” within the meanings of Regulation T, U or X of the Board of Governors of the Federal Reserve System.


  
 14 








 (uu) Solvency. The Company is, and immediately after the Closing Date will be, Solvent. As
used herein, the term “Solvent” means, with respect to any person on a particular date, that on such date (i) the fair market value of the assets of such person is greater than the total amount of liabilities (including contingent
liabilities) of such person, (ii) the present fair salable value of the assets of such person is greater than the amount that will be required to pay the probable liabilities of such person on its debts as they become absolute and mature,
(iii) such person is able to realize upon its assets and pay its debts and other liabilities, including contingent obligations, as they mature and (iv) such person does not have unreasonably small capital. 

(vv) Rated Securities. Except for the Company’s existing 8.000% Senior Notes due 2020 issued pursuant to that certain Indenture
dated as of May 18, 2012 between the Company and the Trustee, at the Time of Sale there were no securities of or guaranteed by the Company that are rated by a “nationally recognized statistical rating organization,” as that term is
defined for purposes of Rule 436 under the Securities Act. 
 (ww) Exchange Act Requirements. The Company has filed in a timely
manner all reports required to be filed pursuant to Sections 13(a), 13(e), 14 and 15(d) of the Exchange Act during the preceding 12 months (except to the extent that Section 15(d) requires reports to be filed pursuant to Sections 13(d) and
13(g) of the Exchange Act, which shall be governed by the next clause of this sentence); and the Company has filed in a timely manner all reports required to be filed pursuant to Sections 13(d) and 13(g) of the Exchange Act since January 1,
2007, except where the failure to timely file could not reasonably be expected individually or in the aggregate to have a Material Adverse Effect. 

(xx) Reserve Reports. The information underlying the estimates of the reserves of the Company included in the Time of Sale Memorandum
and the Offering Memorandum, and which was supplied by the Company to Ryder Scott Company LP (“Ryder Scott”), independent petroleum engineers, for purposes of preparing the Company’s reserve reports (the “Reserve
Reports”), including, without limitation, production, volumes, sales prices for production, contractual pricing provisions under oil or gas sales or marketing contracts under hedging arrangements, costs of operations and development, and
working interest and net revenue interest information relating to the Company’s ownership interests in properties, was true and correct in all material respects on the dates of such Reserve Reports; the estimates of future capital expenditures
and other future exploration and development costs supplied to Ryder Scott were prepared in good faith and with a reasonable basis; the information provided to Ryder Scott by the Company for purposes of preparing the Reserve Reports was prepared in
accordance with customary industry practices; Ryder Scott was, as of the dates of the Reserve Reports, and is, as of the date hereof, independent petroleum engineers with respect to the Company; other than any decrease in reserves resulting from
normal production of the reserves and intervening spot market product price fluctuations disclosed in the Time of Sale Memorandum and the Offering Memorandum, to the knowledge of the Company, there are not any facts or circumstances that would
adversely affect the reserves in the aggregate, or the aggregate present value of future net cash flows therefrom, as disclosed in the Time of Sale Memorandum and the Offering Memorandum and reflected in the Reserve Reports such as to cause a
material adverse change; estimates of such reserves and the present value of the future net cash flows therefrom as disclosed in the Time of Sale Memorandum and the Offering Memorandum and reflected in the


  
 15 








 
Reserve Reports comply in all material respects to the applicable requirements of Regulation S-X and Subpart 1200 of
Regulation S-K under the Securities Act. 
 (yy) Criminal Proceedings. To the best of
the Company’s knowledge, information and belief, none of the current directors or officers of the Company is or has ever been subject to prior regulatory, criminal or bankruptcy proceedings in the U.S. or elsewhere. 

Any certificate signed by an officer of the Company and delivered to the Initial Purchasers or to counsel for the Initial Purchasers shall be deemed to be a
representation and warranty by the Company to each Initial Purchaser as to the matters set forth therein. 
 2. Purchase and Resale of
the Securities. (a) The Company hereby agrees to issue and sell the Securities to the several Initial Purchasers as provided in this Agreement, and each Initial Purchaser, on the basis of the representations, warranties and agreements set
forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the Company the respective principal amount of Securities set forth opposite such Initial Purchaser’s name in Schedule 1
hereto at a price equal to 92.875% of the principal amount thereof (the “Purchase Price”). 
 (b) The Company understands that the
Initial Purchasers intend to offer the Securities for resale on the terms set forth in the Time of Sale Memorandum. Each Initial Purchaser, severally and not jointly, represents, warrants and agrees that: 

(i) it is a qualified institutional buyer (a “QIB”) within the meaning of Rule 144A under the Securities
Act (“Rule 144A”) and an accredited investor within the meaning of Rule 501(a) under the Securities Act; 

(ii) it has not solicited offers for, or offered or sold, such Securities by any form of general solicitation or general
advertising (as those terms are used in Regulation D under the Securities Act) or in any manner involving a public offering within the meaning of Section 4(2) of the Securities Act; and 

(iii) it has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or sell, the Securities as
part of their initial offering except: 
 (A) within the United States, to persons whom it reasonably believes to be QIBs in
transactions pursuant to Rule 144A under the Securities Act and in connection with each such sale, it has taken or will take reasonable steps to ensure that the purchaser of the Securities is aware that such sale is being made in reliance on
Rule 144A; and 
 (B) in the case of offers outside the United States, to persons other than U.S. persons (“foreign
purchasers,” which term shall include dealers or other professional fiduciaries in the United States acting on a discretionary basis for foreign beneficial owners (other than an estate or trust)) in reliance upon Regulation S under the
Securities Act; 

  
 16 








 and, in each case, such persons purchasing such Securities are deemed to have represented and
agreed as provided in the Offering Memorandum under the caption “Notice to Investors”. 
 (c) Each Initial Purchaser acknowledges
and agrees that the Company and, for purposes of the opinions to be delivered to the Initial Purchasers pursuant to Sections 5(f) and 5(g), counsel for the Company and counsel for the Initial Purchasers, respectively, may rely upon the accuracy
of the representations and warranties of the Initial Purchasers, and compliance by the Initial Purchasers with their agreements, contained in paragraph (b) above, and each Initial Purchaser hereby consents to such reliance. 

(d) The Company acknowledges and agrees that the Initial Purchasers may offer and sell Securities to or through any affiliate of an Initial
Purchaser and that any such affiliate may offer and sell Securities purchased by it to or through any Initial Purchaser. 
 3. Payment
and Delivery. (a) Payment for and delivery of the Securities will be made to the Company in Federal or other funds immediately available in New York City against delivery of the Securities for the respective accounts of the several Initial
Purchasers at the offices of Latham & Watkins LLP at 811 Main Street, Houston, Texas 77002, at 10:00 A.M., New York City time, on May 18, 2015, or at such other time or place on the same or such other date, not later than the fifth
business day thereafter, as the Representative and the Company may agree upon in writing. The time and date of such payment and delivery is referred to herein as the “Closing Date.” The Company hereby acknowledges that circumstances under
which the Representative may provide notice to postpone the Closing Date as originally scheduled include, but are in no way limited to, any determination by the Company or the Initial Purchasers to recirculate to investors copies of an amended or
supplemented Offering Memorandum or a delay as contemplated by the provisions of Section 8 hereof. 
 (b) The Securities shall be in
global form, registered in the name of Cede & Co., as nominee of the DTC, broken out as to principal amount between Securities sold pursuant to Rule 144A and Securities sold pursuant to Regulation S, as advised by the Representative, and
delivered to the Trustee, as custodian for DTC, at Closing. 
 4. Further Agreements of the Company. The Company covenants and agrees
with each Initial Purchaser that: 
 (a) Offering Memorandum, Amendments or Supplements. Before finalizing the Offering Memorandum or
making or distributing any amendment or supplement to any of the Time of Sale Memorandum or the Offering Memorandum, the Company will furnish to the Representative and counsel for the Initial Purchasers a copy of the proposed Offering Memorandum or
such amendment or supplement for review, and will not distribute any such proposed Offering Memorandum, amendment or supplement to which the Representative reasonably objects. 

(b) Additional Written Communications. Before using, authorizing, approving or referring to any written communication (as defined in
the Securities Act) that constitutes an offer to sell or a solicitation of an offer to buy the Securities (a “Company Written 

  
 17 








 
Communication”) (other than written communications that are listed on Exhibit A hereto and the Offering Memorandum), the Company will furnish to the Representative and counsel for the
Initial Purchasers a copy of such written communication for review and will not use, authorize, approve or refer to any such written communication to which the Representative reasonably objects. 

(c) Delivery of Copies. The Company will deliver to the Initial Purchasers as many copies of the Preliminary Offering Memorandum, the
Time of Sale Memorandum and the Offering Memorandum (including all amendments and supplements thereto) as the Initial Purchasers may reasonably request. 

(d) Notice to the Representative. The Company will advise the Representative promptly, and confirm such advice in writing, (i) of
the issuance by any governmental or regulatory authority of any order preventing or suspending the use of any of the Time of Sale Memorandum or the Offering Memorandum or the initiation or threatening of any proceeding for that purpose; (ii) of
the occurrence of any event at any time prior to the completion of the initial offering of the Securities as a result of which any of the Time of Sale Memorandum or the Offering Memorandum as then amended or supplemented would include any untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing when such Time of Sale Memorandum or the Offering Memorandum is delivered to a purchaser, not
misleading; and (iii) of the receipt by the Company of any notice with respect to any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose;
and the Company will use its reasonable best efforts to prevent the issuance of any such order preventing or suspending the use of any of the Time of Sale Memorandum or the Offering Memorandum or suspending any such qualification of the Securities
and, if any such order is issued, will obtain as soon as possible the withdrawal thereof. 
 (e) Blue Sky Compliance. The Company
will cooperate with the Initial Purchasers in arranging for the qualification of the Securities for offering and sale under the securities or “Blue Sky” laws of such jurisdictions as the Initial Purchasers may designate and will continue
such qualifications in effect for as long as may be necessary to complete the resale of the Securities; provided, however, that in connection therewith, the Company shall not be required to qualify as a foreign corporation or to execute a general
consent to service of process in any jurisdiction or subject itself to taxation in excess of a nominal dollar amount in any such jurisdiction where it is not then so subject. 

(f) Agreement Not to Offer or Sell Securities. During the period from the date hereof through and including the date that is 90 days
after the date hereof, neither the Company nor any of its Affiliates, nor any person acting on our or their behalf, will, without the prior written consent of the Representative, directly or indirectly, sell, offer to sell, contract to sell, grant
any option to purchase, issue any instrument convertible into or exchangeable for, or otherwise transfer or dispose of (or enter into any transaction or devise that is designed to, or could be expected to, result in the disposition in the future of)
any debt securities of the Company similar to the Securities (other than the Exchange Securities). 

  
 18 








 (g) Use of Proceeds. The Company will apply the net proceeds from the sale of the
Securities as set forth under “Use of Proceeds” in the Time of Sale Memorandum and the Offering Memorandum. 
 (h) Supplying
Information. While the Securities remain outstanding and are “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act, the Company will, during any period in which the Company is not subject to and in
compliance with Section 13 or 15(d) of the Exchange Act, furnish to holders of the Securities, prospective purchasers of the Securities designated by such holders and securities analysts, in each case upon request, the information required to
be delivered pursuant to Rule 144A(d)(4) under the Securities Act. 
 (i) Updating Information. If, prior to the completion of
the placement of the Securities by the Initial Purchasers, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Offering Memorandum, as then amended or supplemented, in order to make the statements
therein, in the light of the circumstances when the Offering Memorandum is delivered to a subsequent purchaser, not misleading, or if in the reasonable judgment of the Representative and counsel for the Initial Purchasers it is otherwise necessary
to amend or supplement the Offering Memorandum to comply with law, the Company agrees to promptly prepare (subject to this Section 4), and furnish at its own expense to the Initial Purchasers, amendments or supplements to the Offering
Memorandum so that the statements in the Offering Memorandum as so amended or supplemented will not, in the light of the circumstances at the Closing Date and at the time of sale of Securities, be misleading or so that the Offering Memorandum, as
amended or supplemented, will comply with all applicable law. 
 (j) The Depositary. The Company will cooperate with the Initial
Purchasers and use its best efforts to permit the Securities to be eligible for clearance and settlement through the facilities of The Depository Trust Company (“DTC”). 

(k) Indenture Qualification. Prior to any registration of the Securities pursuant to the Registration Rights Agreement, or at such
earlier time as may be so required, the Company shall qualify the Indenture under the Trust Indenture Act and to enter into any necessary supplemental indentures in connection therewith. 

(l) No Resales by the Company. During the period of one year after the Closing Date, neither the Company nor any of its affiliates (as
defined in Rule 144 under the Securities Act), will resell any of the Securities that have been reacquired by any of them. 
 (m) No
Integration. Neither the Company nor any of its affiliates (as defined in Rule 501(b) of Regulation D) will sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in the Securities Act)
which could be integrated with the sale of the Securities in a manner which would require registration under the Securities Act. 
 (n)
No General Solicitation or Directed Selling Efforts. The Company will not engage in any form of general solicitation or general advertising (as those terms are used in 

  
 19 








 
Regulation D under the Securities Act) in connection with the offering of the Securities or in any manner involving a public offering within the meaning of Section 4(2) of the Securities
Act. 
 (o) No Stabilization. The Company will not take, directly or indirectly, any action designed to or that could reasonably be
expected to cause or result in any stabilization or manipulation of the price of the Securities and will not take any action prohibited by Regulation M under the Exchange Act in connection with the distribution of the Securities contemplated hereby.

 5. Conditions of Initial Purchasers’ Obligations. The obligation of each Initial Purchaser to purchase Securities on the
Closing Date as provided herein is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions: 

(a) Representations and Warranties. The representations and warranties of the Company contained herein shall be true and correct on the
date hereof and on and as of the Closing Date, and the statements of the Company and its officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date. 

(b) No Downgrade. Subsequent to the execution and delivery of this Agreement, there shall not have occurred any downgrading, nor shall
any notice have been given of any intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded the Company or any of its securities or indebtedness by
any “nationally recognized statistical rating organization” as such term is defined for purposes of Rule 436 under the Securities Act. 

(c) No Material Adverse Effect. There shall not have occurred a Material Adverse Effect, which in the judgment of the Representative
makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Memorandum and the Offering Memorandum. 

(d) Officers’ Certificate. On the Closing Date the Initial Purchasers shall have received a written certificate executed by the
Chairman of the Board, Chief Executive Officer or President of the Company and the Chief Financial Officer or Chief Accounting Officer of the Company, dated as of the Closing Date, to the effect set forth in Section 5(b) hereof, and further to
the effect that: 
 (i) for the period from and after the date of this Agreement and prior to the Closing Date there has not
occurred any Material Adverse Effect; 
 (ii) the representations, warranties and covenants of the Company set forth in
Section 1 hereof were true and correct as of the date hereof and are true and correct as of the Closing Date with the same force and effect as though expressly made on and as of the Closing Date; and 

  
 20 








 (iii) the Company has complied with all the agreements and satisfied all the
conditions on its part to be performed or satisfied at or prior to the Closing Date. 
 (e) Comfort Letters. On the date hereof, the
Initial Purchasers shall have received from each of the Independent Accountants a comfort letter dated the date hereof, in form and substance satisfactory to counsel for the Initial Purchasers with respect to the audited and any unaudited financial
information in the Preliminary Offering Memorandum. On the Closing Date, the Initial Purchasers shall have received from each of the Independent Accountants a comfort letter dated the Closing Date, in form and substance satisfactory to counsel for
the Initial Purchasers, which shall extend to the financial information, if any, contained in the Offering Memorandum and not contained in the Preliminary Offering Memorandum. 

(f) Opinion of Counsel for the Company. Faegre Baker Daniels LLP, counsel for the Company, shall have furnished to the Initial
Purchasers, at the request of the Company, their written opinion, dated the Closing Date and addressed to the Initial Purchasers, in form and substance reasonably satisfactory to the Initial Purchasers, to the effect set forth in Exhibit C hereto.

 (g) Opinion of Counsel for the Initial Purchasers. The Initial Purchasers shall have received on and as of the Closing Date an
opinion of Latham & Watkins LLP, counsel for the Initial Purchasers, with respect to such matters as the Initial Purchasers may reasonably request, and such counsel shall have received such documents and information as they may reasonably
request to enable them to pass upon such matters. 
 (h) No Legal Impediment to Issuance. No action shall have been taken and no
statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities; and no injunction
or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities. 

(i) Good Standing. The Initial Purchasers shall have received on and as of the Closing Date satisfactory evidence of the good standing
of the Company in its jurisdiction of incorporation and its good standing in such other jurisdictions as the Representative may reasonably request, in each case in writing or any standard form of telecommunication, from the appropriate governmental
authorities of such jurisdictions. 
 (j) Indenture and Registration Rights Agreement. The Initial Purchasers shall have received a
counterpart of the Indenture and the Registration Rights Agreement that shall have been executed and delivered by a duly authorized officer of the Company. 

(k) Additional Documents. On or prior to the Closing Date, the Initial Purchasers and counsel for the Initial Purchasers shall have
received such information, documents and opinions as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the Securities as contemplated herein, or in order to evidence


  
 21 








 
the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions or agreements, herein contained. 

All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to comply with the provisions
hereof only if they are in form and substance reasonably satisfactory to counsel for the Initial Purchasers. 
 6. Indemnification and
Contribution. 
 (a) Indemnification of the Initial Purchasers. The Company agrees to indemnify and hold harmless each Initial
Purchaser, its agents, affiliates, directors and officers and each person, if any, who controls any Initial Purchaser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any losses, claims,
damages or liabilities (including, without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that arise out of, or
are based upon, (i) any untrue statement or alleged untrue statement made by the Company in Section 1 hereof, (ii) any untrue statement or alleged untrue statement of any material fact contained in the Preliminary Offering Memorandum,
the Time of Sale Memorandum, any Company Written Communication or the Offering Memorandum (or any amendment or supplement thereto), or (iii) any omission or alleged omission to state, in the Preliminary Offering Memorandum, the Time of Sale
Memorandum, any Company Written Communication prepared by or on behalf of, used by or referred to by the Company or the Offering Memorandum (or any amendment or supplement thereto), a material fact required to be stated therein or necessary to make
the statements therein not misleading in the light of the circumstances under which they were made not misleading in each case, except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or
omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly for
use therein. 
 (b) Indemnification of the Company. Each Initial Purchaser agrees, severally and not jointly, to indemnify and hold
harmless the Company, its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in
paragraph (a) above, but only with reference to information relating to such Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representative expressly for use in the Preliminary Offering Memorandum,
the Time of Sale Memorandum, any Company Written Communication prepared by or on behalf of, used by or referred to by the Company, or the Offering Memorandum (or any amendment or supplement thereto), it being understood and agreed that the only such
information consists of the statements set forth in the third, tenth, eleventh and twelfth paragraphs under the caption “Plan of Distribution” in the Preliminary Offering Memorandum and the Offering Memorandum. 

(c) Notifications and Procedures. If any suit, action, proceeding (including any governmental or regulatory investigation), claim or
demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a) or (b) of this Section 6, such person (the “Indemnified Party”) shall promptly


  
 22 








 
notify the person against whom such indemnification may be sought (the “Indemnifying Party”) in writing; provided that the failure to notify the Indemnifying Party shall not
relieve it from any liability that it may have under this Section 6 except to the extent that it has been materially prejudiced as a proximate result of such failure; and provided, further, that the failure to notify the Indemnifying Party
shall not relieve it from any liability that it may have to an Indemnified Party otherwise than under paragraph (a) or (b) under this Section 6, as applicable. If any such proceeding shall be brought or asserted against an Indemnified
Party and it shall have notified the Indemnifying Party thereof, the Indemnifying Party shall retain counsel reasonably satisfactory to the Indemnified Party to represent the Indemnified Party and any others the Indemnifying Party may designate in
such proceeding and shall pay the fees and disbursements of such counsel related to such proceeding. In any such proceeding, any Indemnified Party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at
the expense of such Indemnified Party unless (i) the Indemnifying Party and the Indemnified Party shall have mutually agreed to the contrary; (ii) the Indemnifying Party has failed within a reasonable time to retain counsel reasonably
satisfactory to the Indemnified Party; (iii) the defendants in any such proceeding include both the Indemnified Party and the Indemnifying Party and the Indemnified Party shall have been advised by counsel that there may be one or more legal
defenses available to it and/or other Indemnified Parties that are different from or additional to those available to the Indemnifying Party, or (iv) the named parties in any such proceeding (including any impleaded parties) include both the
Indemnifying Party and the Indemnified Party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Party shall
not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Parties and that all such fees and
expenses shall be reimbursed as they are incurred. Such firm shall be designated in writing by the Representative, in the case of parties indemnified pursuant to Section 6(a), and by the Company, in the case of parties indemnified pursuant to
Section 6(b). 
 (d) Settlements. The Indemnifying Party shall not be liable for any settlement of any proceeding effected
without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Party agrees to indemnify each Indemnified Party from and against any loss or liability by reason of such settlement or
judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified Party shall have requested that an Indemnifying Party reimburse the Indemnified Party for fees and expenses of counsel as contemplated by Section 6(c), the
Indemnifying Party shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by the Indemnifying Party of such request and (ii) the
Indemnifying Party shall not have reimbursed the Indemnified Party in accordance with such request prior to the date of such settlement. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement,
compromise or consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect of which any Indemnified Party is or could have been a party and indemnity was or could have been sought hereunder by such Indemnified
Party, unless such settlement, compromise or consent (i) includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such action, suit or proceeding and (ii) does not include any
statements as to or any findings of fault, culpability or failure to act by or on behalf of any Indemnified Party. 

  
 23 








 (e) Contribution. If the indemnification provided for in paragraphs (a) and
(b) above is unavailable to an Indemnified Party or otherwise insufficient to hold harmless an Indemnified Party in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Party under such paragraph
shall contribute to the amount paid or payable by such Indemnified Party as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one
hand and the Initial Purchasers on the other from the offering of the Securities pursuant to this Agreement or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to
reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company on the one hand and the Initial Purchasers on the other in connection with the statements or omissions or inaccuracies in the
representations and warranties herein that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Initial Purchasers on
the other shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the Securities and the total discounts and commissions received by the Initial Purchasers in
connection therewith, as provided in this Agreement, bear to the aggregate offering price of the Securities. The relative fault of the Company on the one hand and the Initial Purchasers on the other shall be determined by reference to, among other
things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact or any such inaccurate or alleged inaccurate representation or warranty relates to information supplied by the
Company, on the one hand, or the Initial Purchasers, on the other hand, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission or inaccuracy. 

(f) Limitation on Liability. The Company and the Initial Purchasers agree that it would not be just and equitable if contribution
pursuant to this Section 6 were determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations
referred to in paragraph (e) above. The amount paid or payable by an Indemnified Party as a result of the losses, claims, damages and liabilities referred to in paragraph (e) above shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses incurred by such Indemnified Party in connection with any such action or claim. Notwithstanding the provisions of this Section 6, in no event shall an Initial Purchaser be required to contribute any
amount in excess of the total discounts and commissions received by such Initial Purchaser in connection with the Securities distributed by it. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Initial Purchasers’ obligations to contribute pursuant to this Section 6 are several in proportion to their
respective purchase obligations hereunder and not joint. 
 (g) Non-Exclusive Remedies. The remedies provided for in this
Section 6 are not exclusive and shall not limit any rights or remedies that may otherwise be available to any Indemnified Party at law or in equity. 

7. Termination. This Agreement may be terminated in the absolute discretion of the Representative, by notice to the Company, if after
the execution and delivery of 

  
 24 








 
this Agreement and on or prior to the Closing Date (i) trading generally shall have been suspended or materially limited on, or by, as the case may be, any of the New York Stock Exchange,
the NYSE MKT, the NASDAQ Global Market, the Chicago Board of Options Exchange, the Chicago Mercantile Exchange or the Chicago Board of Trade, (ii) trading of any securities of the Company shall have been suspended on any exchange or in any over-the-counter market; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; (iv) material
disruption in securities settlement, payment or clearance services in the United States shall have occurred, or (v) there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or
crisis, either within or outside the United States, that, in the judgment of the Representative, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in
the manner contemplated by this Agreement, the Time of Sale Memorandum and the Offering Memorandum. Termination of this Agreement pursuant to this Section 7 shall be without liability of any party to any other party except as provided in
Section 6 hereof and the Company shall be obligated to reimburse the expenses of the Initial Purchasers pursuant to Section 9(b). 

8. Defaulting Initial Purchaser. (a) If, on the Closing Date, any one or more of the Initial Purchasers defaults on its obligation
to purchase Securities that it or they have agreed to purchase hereunder, and the aggregate principal amount of Securities which such defaulting Initial Purchaser or Initial Purchasers agreed but failed or refused to purchase does not exceed one-tenth of the aggregate principal amount of Securities to be purchased on the Closing Date, the other Initial Purchasers shall be obligated, severally, in the proportions that the principal amount of Securities
set forth opposite their respective names on Schedule 1 bears to the aggregate principal amount of Securities set forth opposite the names of all such non-defaulting Initial Purchasers, or in such other proportions as may be specified by the
Initial Purchasers with the consent of the non-defaulting Initial Purchasers, to purchase the Securities which such defaulting Initial Purchaser or Initial Purchasers agreed but failed or refused to purchase on the Closing Date; provided that
in no event shall the principal amount of Securities that any Initial Purchaser has agreed to purchase pursuant to this Agreement be increased pursuant to this Section 8 by an amount in excess of
one-ninth of such principal amount of Securities without the written consent of such Initial Purchaser. 

(b) If any one or more of the Initial Purchasers shall fail or refuse to purchase Securities and the aggregate number of Securities which it
or they have agreed to purchase hereunder on the Closing Date and the aggregate principal amount of Securities with respect to which such default occurs is more than one-tenth of the aggregate principal amount
of Securities to be purchased on Closing Date, and arrangements satisfactory to the Initial Purchasers and the Company for the purchase of such Securities are not made within 48 hours after such default, this Agreement shall terminate without
liability on the part of any non-defaulting Initial Purchaser or of the Company. In any such case either the Initial Purchasers or the Company shall have the right to postpone the Closing Date, but in no event
for longer than seven days, in order that the required changes, if any, in the Time of Sale Memorandum, the Offering Memorandum or in any other documents or arrangements may be effected. 

  
 25 








 (c) Nothing contained herein shall relieve a defaulting Initial Purchaser of any liability it may
have to the Company or any non-defaulting Initial Purchaser for damages caused by its default. 
 9. Payment of Expenses.
(a) The Company agrees to pay all costs and expenses incident to the performance of its obligations under this Agreement, whether or not the transactions contemplated herein are consummated or this Agreement is terminated pursuant to
Section 7 or Section 8(b) hereof, including all costs and expenses incident to (i) the cost of production and printing of documents with respect to the transactions contemplated hereby, including any costs of printing the Preliminary
Offering Memorandum, the Time of Sale Memorandum and any Offering Memorandum and any amendment or supplement thereto, and any “Blue Sky” memoranda, (ii) all arrangements relating to the delivery to the Initial Purchasers of copies of
the foregoing documents, (iii) the fees, disbursements and expenses of the Company’s counsel and the Independent Accountants in connection with the issuance and sale of the Securities, (iv) all costs and expenses related to the
transfer and delivery of the Securities to the Initial Purchasers, including any stamp, transfer or other taxes payable thereon, (v) the qualification of the Securities under state securities and “Blue Sky” laws, including filing fees
and reasonable fees and disbursements of counsel for the Initial Purchasers relating thereto, (vi) any fees charged by rating agencies for the rating of the Securities, (vii) all fees and expenses (including reasonable fees and expenses of
counsel) of the Company in connection with approval of the Securities by the DTC for “book-entry” transfer, and the performance by the Company of its other obligations under this Agreement, (viii) the costs and charges of the Trustee
including fees and expenses of counsel, (ix) the costs and expenses of the Company relating to investor presentations on any “road show” undertaken in connection with the marketing of the offering of the Securities, including, without
limitation, expenses associated with the preparation or dissemination of any electronic road show, expenses associated with production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show
presentations with the prior approval of the Company, and travel and lodging expenses of the representatives and officers of the Company and any such consultants, (x) the document production charges and expenses associated with printing this
Agreement, (xi) any filing fees incident to, and any reasonable fees and disbursements of counsel to the Initial Purchasers in connection with the review by the Financial Industry Regulatory Authority, if any, of the terms of the sale of the
Securities or the Exchange Securities, and (xii) all other costs and expenses incident to the performance of the obligations of the Company hereunder for which provision is not otherwise made in this Section. 

(b) It is understood, however, that if (i) this Agreement is terminated pursuant to Section 7 or Section 8(b), (ii) the
Company for any reason fails to tender the Securities for delivery to the Initial Purchasers or (iii) the Initial Purchasers decline to purchase the Securities for any reason permitted under this Agreement, the Company agrees to reimburse the
Initial Purchasers for all out-of-pocket costs and expenses (including the reasonable fees and expenses of their counsel) reasonably incurred by the Initial Purchasers in connection with this Agreement and the offering contemplated hereby. 

10. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the parties hereto and
their respective successors and any controlling persons referred to herein, and the affiliates, officers and directors of each Initial 

  
 26 








 
Purchaser referred to in Section 6 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in
respect of this Agreement or any provision contained herein. No purchaser of Securities from any Initial Purchaser shall be deemed a successor merely by reason of such purchase. 

11. Survival. The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the
Initial Purchasers contained in this Agreement or made by or on behalf of the Company or the Initial Purchasers pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Securities and
shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Initial Purchasers. 

12. No Advisory or Fiduciary Responsibility. The Company acknowledges and agrees that (i) the purchase and sale of the Securities
pursuant to this Agreement is an arm’s-length commercial transaction between the Company, on the one hand, and the Initial Purchasers, on the other, (ii) in connection therewith and with the process
leading to such transaction each Initial Purchaser is acting solely as a principal and not the agent or fiduciary of the Company, (iii) no Initial Purchaser has assumed an advisory or fiduciary responsibility in favor of the Company with
respect to the offering contemplated hereby or the process leading thereto (irrespective of whether such Initial Purchaser has advised or is currently advising the Company on other matters) or any other obligation to the Company except the
obligations expressly set forth in this Agreement and (iv) the Company has consulted its own legal and financial advisors to the extent it deemed appropriate. The Company agrees that it will not claim that any Initial Purchaser has rendered
advisory services of any nature or respect, or owes a fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto. 

This Agreement supersedes all prior agreements and understandings (whether written or oral) between the Company and the several Initial
Purchasers, or any of them, with respect to the subject matter hereof. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the several Initial Purchasers with respect to any
breach or alleged breach of fiduciary duty. 
 13. Authority of the Representative. Any action by the Initial Purchasers hereunder
may be taken by the Representative on behalf of the Initial Purchasers, and any such action taken by the Representative shall be binding upon the Initial Purchasers. 

14. Partial Unenforceability. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not
affect the validity or enforceability of any other section, paragraph or provision hereof. If any section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such
minor changes (and only such minor changes) as are necessary to make it valid and enforceable. 

  
 27 








 15. Notices. All notices and other communications hereunder shall be in writing and shall
be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. 
 If to the Initial
Purchasers: 
  

			
	RBC Capital Markets, LLC
	Three World Financial Center
	200 Vesey Street, 10th Floor
	New York, New York 10281-8098
	Facsimile:		212-618-2210
	Attention:		High Yield Capital Markets

 with a copy to: 
  

			
	Latham & Watkins LLP
	811 Main Street, Suite 3700
	Houston, Texas 77002
	Counsel for the Initial Purchasers
	Facsimile:		(713) 546-5401
	Attention:		J. Michael Chambers

 If to the Company: 
  

			
	Northern Oil and Gas, Inc.
	315 Manitoba Avenue, Suite 200
	Wayzata, Minnesota 55391
	Facsimile:		(952) 476-9801
	Attention:		Thomas Stoelk, Chief Financial Officer

 with a copy to: 
  

			
	Faegre Baker Daniels LLP
	2200 Wells Fargo Center
	90 South Seventh Street
	Minneapolis, Minnesota 55402
	Facsimile:		(612) 766-1600
	Attention:		W. Morgan Burns

 16. Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE
STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED WHOLLY THEREIN WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES THEREOF. 

17. Counterparts. This Agreement may be signed in counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument. 

  
 28 








 18. Headings. The headings of the sections of this Agreement are included for convenience
of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. 
 19. Submission to
Jurisdiction; Waiver of Jury Trial. No proceeding related to this Agreement or the transactions contemplated hereby may be commenced, prosecuted or continued in any court other than the courts of the State of New York located in the City and
County of New York or in the United States District Court for the Southern District of New York, which courts shall have jurisdiction over the adjudication of such matters, and the Company hereby consents to the jurisdiction of such courts and
personal service with respect thereto. The Company hereby waives all right to trial by jury in any proceeding (whether based upon contract, tort or otherwise) in any way arising out of or relating to this Agreement. The Company agrees that a final
judgment in any such proceeding brought in any such court shall be conclusive and binding upon the Company and may be enforced in any other courts in the jurisdiction of which the Company is or may be subject, by suit upon such judgment. 

20. Compliance with USA Patriot Act. The parties hereto acknowledge that in accordance with the requirements of the USA Patriot Act
(Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Initial Purchasers are required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include the
name and address of their respective clients, as well as other information that will allow the Initial Purchasers to properly identify their respective clients. 

[Signature pages follow.] 

  
 29 








 If the foregoing is in accordance with your understanding, please indicate your acceptance of
this Agreement by signing in the space provided below. 
  

					
	Very truly yours,
	
	NORTHERN OIL AND GAS, INC.
		
	By:		 /s/ Thomas W. Stoelk

			Name:		Thomas W. Stoelk
			Title:		Chief Financial Officer



  
 Signature Page to
Purchase Agreement 








 Accepted: 
  

					
	RBC Capital Markets, LLC For itself and on behalf of the several Initial Purchasers listed on Schedule 1 hereto.
	
	RBC Capital Markets, LLC
		
	By:		 /s/ Steve Pedone

			Name:		Steve Pedone
			Title:		Managing Director


  
 Signature Page to
Purchase Agreement